Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 9, 2015 - Issue
Submit an article Journal homepage
103
Views
36
CrossRef citations to date
0
Altmetric
Review

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Aleksander Lenert1 Division of Rheumatology, University of Kentucky, Kentucky Clinic, Lexington, KY, USA
&
Petar Lenert2 Division of Immunology, Department of Internal Medicine, The University of Iowa, Iowa City, IA, USACorrespondence[email protected]
Pages 333-347 | Published online: 07 Jan 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.